Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Activates apoptosis.. Additionally we are shipping CIDEB Proteins (6) and many more products for this protein.
Showing 10 out of 107 products:
Human Polyclonal CIDEB Primary Antibody for EIA, IHC (p) - ABIN499631
Inohara, Koseki, Chen, Wu, Núñez: CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. in The EMBO journal 1998
Show all 2 references for ABIN499631
Human Polyclonal CIDEB Primary Antibody for EIA, IHC (p) - ABIN499633
Inohara, Koseki, Chen, Benedict, Núñez: Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD. in The Journal of biological chemistry 1999
Show all 2 references for ABIN499633
Human Polyclonal CIDEB Primary Antibody for IF, IHC - ABIN1534431
Lugovskoy, Zhou, Chou, McCarty, Li, Wagner: Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. in Cell 2000
Human Polyclonal CIDEB Primary Antibody for WB - ABIN2792228
Da, Li, Yokoyama, Li, Zhao: Dual promoters control the cell-specific expression of the human cell death-inducing DFF45-like effector B gene. in The Biochemical journal 2006
ICAD (show DFFA Antibodies) cDNA was 844-bp in length, containing a 522-bp open reading frame which encoded a protein of 174 amino acids.
CIDEB downregulation may contribute to HCV-induced hepatic steatosis
CIDEB can act as an anti-HCV host factor and contribute to altered triglyceride homeostasis.
Authors found CIDEB to be an essential cofactor for hepatitis C virus entry into hepatocytes.
this work highlights CIDEB's role in lipid droplet (LD) fusion, and presents a new model system to study the PGC-1alpha (show PPARGC1A Antibodies)/CIDEB pathway's role in LD dynamics and the VLDL pathway.
CIDE proteins expression correlate with tumor and survival characteristics in patients with renal cell carcinoma (show MOK Antibodies).
PGC-1alpha (show PPARGC1A Antibodies) plays an important role in partitioning cytoplasmic TG toward the VLDL secretory compartments and promoting VLDL secretion via transcriptional induction of CideB.
A novel mechanism for the cell-specific transcription of the human CIDE-B gene, which involves epigenetic and genetic control at separate respective promoters is reported.
Data (including data from studies in knockout mice) suggest Cideb promotes lipid storage as droplets in hepatocytes under normal diet conditions; Cidea (show CIDEA Antibodies)/Cidec (show CIDEC Antibodies) promote fusion of lipid droplets leading to liver steatosis in fasting (16h) and obese mice.
Cideb and perilipin 2 (show PLIN2 Antibodies) play opposing roles in controlling VLDL lipidation and hepatic lipid homeostasis
SREBP-1c (show SREBF1 Antibodies) mediates the effect of insulin (show INS Antibodies) on the expression of Cidea (show CIDEA Antibodies) in mouse hepatocytes.
Data suggest that Cideb is a novel regulator in controlling cholesterol homeostasis in the liver.
Cideb is a novel important regulator in lipid metabolism in the liver and may thus represent a new therapeutic target for the treatment of obesity, diabetes, and liver steatosis
Cideb protein promotes the formation of triacylglycerol-enriched VLDL particles and provides a molecular insight into VLDL lipidation and maturation in hepatocytes.
cell death-inducing DFFA-like effector b
, cell death-inducing DNA fragmentation factor, alpha subunit-like effector B
, cell death activator CIDE-B
, cell death activator cide-b
, Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B)
, DFFA-like B
, cell death-inducing DFFA-like effector B